CTSB and breast neoplasm: Meanwhile, FRRG-MMAE nanoparticles significantly minimized the MMAE-related toxicity toward normal tissues owing to their innately low cathepsin B. As a result, efficient tumor delivery of MMAE by FRRG-MMAE nanoparticles greatly inhibited the breast tumor growth with minimal side effects.